SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001047469-08-007048
Filing Date
2008-05-30
Accepted
2008-05-29 20:45:35
Documents
7
Period of Report
2008-05-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a2186005z8-k.htm 8-K 67214
2 EXHIBIT 2.1 a2186005zex-2_1.htm EX-2.1 875377
3 EXHIBIT 4.1 a2186005zex-4_1.htm EX-4.1 38215
4 EXHIBIT 10.1 a2186005zex-10_1.htm EX-10.1 125646
5 EXHIBIT 10.1.1 a2186005zex-10_11.htm EX-10.1.1 5061
6 EXHIBIT 10.2 a2186005zex-10_2.htm EX-10.2 81355
7 EXHIBIT 10.2.1 a2186005zex-10_21.htm EX-10.2.1 2960
  Complete submission text file 0001047469-08-007048.txt   1197412
Mailing Address 1522 217TH PLACE S.E. BOTHELL WA 98021
Business Address 1522 217TH PLACE S.E. BOTHELL WA 98021 4254879500
SONUS PHARMACEUTICALS INC (Filer) CIK: 0000949858 (see all company filings)

IRS No.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21243 | Film No.: 08868284
SIC: 2835 In Vitro & In Vivo Diagnostic Substances